Literature DB >> 9272166

Angiotensin-converting enzyme (ACE) gene polymorphisms in patients characterised by coronary angiography.

C A Foy1, G I Rice, N Ossei-Gerning, M W Mansfield, P J Grant.   

Abstract

The angiotensin converting enzyme (ACE) gene is implicated as a risk factor for coronary artery disease and myocardial infarction (MI). An insertion/deletion (I/D) polymorphism is believed to be in linkage disequilibrium with a functional site elsewhere. Ten polymorphisms have recently been identified in the ACE gene. We screened patients undergoing coronary angiography (n = 258) for six of these polymorphisms (T-5491C, T-93C, A-240T, T1237C, D/I and 4656(CT)2/3), and identified a further two rare polymorphisms. ACE levels were associated with genotype for all polymorphisms analysed individually by one way ANOVA (P < 0.0005). The polymorphisms occurring in the 5' region were in negative linkage disequilibrium with the exonic and 3' region polymorphisms. The A-240T polymorphism had the greatest association with ACE levels (R2 = 14%); none of the others were significantly associated with levels when adjustment was made for A-240T. None of the polymorphisms were associated with the extent of coronary atheroma. Two of the promoter polymorphisms (A-240T and T-93C) were weakly related to the occurrence of MI (P = 0.03 and P = 0.05, respectively, by chi 2 analysis). The TT genotype of A-240T appeared to be protective against MI with an odds ratio of 0.31 (95% confidence interval, 0.12, 0.83). These findings indicate that polymorphisms in the ACE gene promoter region may have a stronger association with disease than the I/D polymorphism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9272166     DOI: 10.1007/s004390050527

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion.

Authors:  Tadashi Suehiro; Tatsuhito Morita; Mari Inoue; Yoshitaka Kumon; Yukio Ikeda; Kozo Hashimoto
Journal:  Hum Genet       Date:  2004-05-26       Impact factor: 4.132

2.  An angiotensin converting enzyme haplotype predicts survival in patients with end stage renal disease.

Authors:  James B Wetmore; Kirsten L Johansen; Saunak Sen; Adriana M Hung; David H Lovett
Journal:  Hum Genet       Date:  2006-06-22       Impact factor: 4.132

Review 3.  Genetic risk factors and restenosis after percutaneous coronary interventions.

Authors:  A Kastrati; J Dirschinger; A Schömig
Journal:  Herz       Date:  2000-02       Impact factor: 1.443

4.  Gender specificity of a genetic variant of angiotensin-converting enzyme and risk of coronary artery disease.

Authors:  Negar Firouzabadi; Nader Tajik; Ehsan Bahramali; Hooman Bakhshandeh; Mohsen Maadani; Massoumeh Shafiei
Journal:  Mol Biol Rep       Date:  2013-05-10       Impact factor: 2.316

5.  Polymorphism of angiotensin-1 converting enzyme gene and Kawasaki disease.

Authors:  S-F Wu; J-S Chang; C-T Peng; Y-R Shi; F-J Tsai
Journal:  Pediatr Cardiol       Date:  2004-05-28       Impact factor: 1.655

6.  Angiotensin converting enzyme gene polymorphism is associated with severity of coronary artery disease in men with high total cholesterol levels.

Authors:  Joanna Borzyszkowska; Anna Stanislawska-Sachadyn; Marcin Wirtwein; Wojciech Sobiczewski; Dariusz Ciecwierz; Radoslaw Targonski; Marcin Gruchala; Andrzej Rynkiewicz; Janusz Limon
Journal:  J Appl Genet       Date:  2012-02-04       Impact factor: 3.240

7.  Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression.

Authors:  M L Ancelin; I Carrière; J Scali; K Ritchie; I Chaudieu; J Ryan
Journal:  Transl Psychiatry       Date:  2013-11-05       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.